|Slideshows|January 17, 2022

Remembering Martin Luther King Jr in 2022

May his words and ideals continue to inspire...

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Assessment of Suicide Risk in Individuals With Schizophrenia

ByCarla Kotzé, PhD, MMed, MPhil, FCPsych,Johannes Lodewikus Roos, MD, DSc, MMed, FCPsych

June 17th 2026

Safety and Efficacy of Intranasal Esketamine for Major Depressive Disorder and Treatment-Resistant Depression

ByNick Ratzloff, DO,Ayse K. Coskun, MD,Kari Wolatz, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

June 15th 2026

Podcast: Limitations of Current Diagnosis-Based Frameworks in Suicide Research. A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

ByJenessa Johnston, PhD,Jill M. Harkavy-Friedman, PhD,Elizabeth Ballard, PhD

June 11th 2026

Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

ByJenessa Johnston, PhD,Jill M. Harkavy-Friedman, PhD,Elizabeth Ballard, PhD

June 11th 2026

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings

ByAmit Etkin, MD, PhD

June 9th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Remembering Martin Luther King Jr in 2022

Related Content

Assessment of Suicide Risk in Individuals With Schizophrenia

Safety and Efficacy of Intranasal Esketamine for Major Depressive Disorder and Treatment-Resistant Depression

Podcast: Limitations of Current Diagnosis-Based Frameworks in Suicide Research. A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings

Latest CME

Southern California Psychiatry Conference

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults

How Can Sleep Disruption Trigger Mood Episodes?

Evaluating Transdermal Asenapine in Schizophrenia

What Should Psychiatrists Know About Pediatric Sleep Apnea and Insomnia Treatment?